SUTENT Adverse Event: Palmar-plantar erythrodysaesthesia syndrome
SUTENT Adverse Event: Palmar-plantar erythrodysaesthesia syndrome is one of 4,500 adverse events in the FDATracker dataset. Key details — Primary drug: SUTENT; Product category: Drug; Primary reaction: Palmar-plantar erythrodysaesthesia syndrome.
| Primary drug | SUTENT |
|---|---|
| Product category | Drug |
| Primary reaction | Palmar-plantar erythrodysaesthesia syndrome |
| All reactions | Palmar-plantar erythrodysaesthesia syndrome; Off label use; Neuropathy peripheral; Disease progression; Thyroid cancer metastatic |
| Seriousness | Not serious |
| Patient outcome | Recovered/Resolved |
| Patient sex | Female |
| All drugs reported | SUTENT; SUTENT; SUTENT; LISINOPRIL |
| Reporter country | US |
| Reporter type | 1 |
| Report date | 20140313 |
| Report ID | 10006642 |
$299/mo
Try FDATracker →